Steffes Lea C, Kumar Maya E, Varghese Nidhy P
Division of Pulmonology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California.
Division of Pulmonology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
Curr Opin Pediatr. 2025 Jun 1;37(3):278-288. doi: 10.1097/MOP.0000000000001459. Epub 2025 Mar 28.
Pulmonary vascular disease is more common in certain genetic developmental lung disorders. This review synthesizes clinical descriptions, molecular analyses, and single-cell transcriptional data to build a conceptual framework to help understand why some variants affect the vasculature while others primarily manifest with parenchymal disease.
Genes predominantly expressed in endothelial and mesenchymal compartments ( TBX4 , FGF10 , FOXF1 , KDR ) commonly present with both parenchymal and pulmonary vascular disease, while epithelial-restricted genes ( SFTPC , ABCA3 , NKX2.1 ) typically manifest as parenchymal disease. Single-cell analyses reveal that compartment-specific expression patterns correlate with clinical phenotypes. Phenotypic variability, even among individuals sharing identical variants, suggests complex interactions between genetic modifiers, epigenetic factors, and developmental processes that remain poorly understood.
Compartment-specific gene expression patterns fundamentally underlie the differential presence of vascular phenotypes in DEVLDs. Genetic advances and single cell technologies have revolutionized our understanding of these disorders, but we are in the early stages of translating this knowledge into meaningful clinical advances. Future efforts must bridge this gap to transform clinical care from supportive to targeted, disease-modifying treatment based on cell-specific molecular mechanisms.
肺血管疾病在某些遗传性发育性肺部疾病中更为常见。本综述综合了临床描述、分子分析和单细胞转录数据,构建了一个概念框架,以帮助理解为什么有些变异会影响脉管系统,而另一些变异主要表现为实质性疾病。
主要在内皮和间充质区室表达的基因(TBX4、FGF10、FOXF1、KDR)通常同时伴有实质性疾病和肺血管疾病,而上皮限制性基因(SFTPC、ABCA3、NKX2.1)通常表现为实质性疾病。单细胞分析表明,区室特异性表达模式与临床表型相关。即使在具有相同变异的个体中,表型变异性也表明遗传修饰因子、表观遗传因素和发育过程之间存在复杂的相互作用,而我们对此仍知之甚少。
区室特异性基因表达模式从根本上是发育性遗传性肺部疾病中血管表型差异存在的基础。遗传学进展和单细胞技术彻底改变了我们对这些疾病的理解,但我们仍处于将这些知识转化为有意义的临床进展的早期阶段。未来的努力必须弥合这一差距,将临床护理从支持性治疗转变为基于细胞特异性分子机制的靶向性、疾病修饰性治疗。